Multicentric Castleman's disease in two cases

Indian Journal of Pediatrics

Volumn 74, Issue 12, 2007, Pages 1116-1120

  Sharma, Rajni ^a   Seth, Rachna ^a   Thavaraj, V ^a   Bagga, A ^a   Kabra, S K ^a   Karak, A K ^a   Atri, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asplenia; Lymphoproliferative disorder; Multicentric castleman's disease

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BENZATHINE PENICILLIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN G; MICROSOMAL AMINOPEPTIDASE; PREDNISOLONE; STEROID; VINCRISTINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SMEAR; CASE REPORT; CHILD; DISEASE DURATION; DISEASE SEVERITY; FEVER; FOLLOW UP; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IRON DEFICIENCY ANEMIA; LEUKOCYTE COUNT; LYMPH NODE BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PLEURA EFFUSION; PNEUMONIA; PROTHROMBIN TIME; SWELLING; TREATMENT FAILURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CHILD; FOLLOW-UP STUDIES; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PREDNISOLONE; RISK ASSESSMENT;

EID: 38349103380     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0210-z     Document Type: Article

References (23)

1. Castleman B, Iverson L, Menendez VP. Localied mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9: 822.
2. Frizzera G. Atypical lymphoproliferative disorders. In Knowles DM, ed Neoplastic Hematopathology. Baltimore MD; Williams and Wilkins, 1992; 454-495.
3. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988; 5: 346-364.
4. Salisbury JR. Castleman's disease in childhood and adolescence. Pediatr Pathol 1990; 10: 609-615.
5. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985; 3: 1202-1215.
6. Kessler E. Multicentric giant lymph node hyperplasia. Report of seven cases. Cancer 1985; 56: 2446-2451.
7. Fisher ER, Sieracki JC, Goldenberg DM. Identity and nature of isolated lymphoid tumors (so-called nodal hyperplasia, hamartoma and angiomatous hamartoma) as revealed by histologic, electron microscopic, and heterotransplantation studies. Cancer 1970; 25: 1286-1300.
8. Bassan Smir N, Greiner TC, Weisenburger DD. Multicentric lymph node hyperplasia in children: a clinicopathologic study of eight patients. Mod Pathol 1996; 9: 1135-1142.
9. Parez N, Bader-Meunier B, Roy CC, Dommergues JP. Paediatric Castleman's disease: report of seven cases and review of the literature. Eur J Pediatr 1999; 158: 631-637.
10. Kosucu P, Ahmetoglu A, Imamoglu M, Cay A, Cobanoglu U, Gumele HR. Multicentric Castleman's Disease in a child with subpectoral involvement. Pediatr Radiol 2003 Aug; 33: 570-573.
11. Baserga M, Rosin M, Schoen M, Young G. Multifocal Castleman disease in pediatrics: case report. Pediatr Hematol Oncol 2005 Dec; 27: 666-669.
12. Samoszuk M, Ramzi E, Ravel J. Disseminated persistant lymphoid hyperplasia containing Epstein Barr virus and clonal rearrangements of DNA. Diagn Mol Pathol 1993; 2: 57-60.
13. Bjarnason I, Cotes PM, Knowles S et al. Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Gastroenterology 1984; 87: 216-223.
14. Yoshizaki K, Matsuda T, Nishimoto N et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360-1367.
15. Nishimoto N, Sasai M, Shima Y et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000; 95: 56-61.
16. Iyonaga K, Ichikado K, Muranaka H et al. Multicentric Castleman's Disease Manifesting in the Lung: Clinical, Radiogaphic and Pathologic Findings and Successful Treatment with Corticosteroid and Cyclophosphamide. Internal Medicine 2003; 42: 182-186.
17. Chronowski GM, Ha CS, Wilder RB et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670-676.
18. Soulier J, Grollet L, Oksenhendler E et al. Kaposi's sarcoma associated herpes virus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276.
19. Gessain A, Sudaka A, Briere J et al. Kaposi sarcoma-associated herpes like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: Is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87: 414.
20. Carrington P, Anderson H, Harris M et al. Auto-immune cytopenias in Castleman's disease. Am J Clin Pathol 1990; 94: 101-104.
21. Said R, Tarawneh M. Membraneoprolierative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Am J Nephrol 1992;12: 466-470.
22. Kinney MC, Hummell DS, Villiger PM et al. Increased interleukin-6 (IL-6) production in a young child with clinical and pathological features of multicentric Castleman's disease. J Clin Immunol 1994; 14: 382-391.
23. Biggar RJ, Frisch M, Geodart JJ. Risk of cancer in children with AIDS. JAMA 2000; 284: 205-209.